f you've been hearing about Ozempic, Wegovy, Mounjaro, Zepbound, and other GLP-1 medications, you're not alone. These medications have become one of the biggest healthcare topics in America, but many Medicare beneficiaries still have questions about what they are, how they work, and why Medicare has historically not covered them for weight loss.
That's why we chose this topic for the very first episode of our new educational series, Medicare Maze.
In Medicare Maze Episode 1, Rick and Carter Thomas discuss what GLP-1 medications actually are, why they've become so popular, and why Medicare's rules have made access difficult for many people. They also begin laying the foundation for an important discussion about upcoming changes that may affect Medicare beneficiaries in the future.
This episode is designed to help you understand the facts before diving into the details of future Medicare-related changes involving GLP-1 medications. Whether you're currently taking one of these medications, considering one, or simply trying to understand what all the headlines mean, this episode is a great place to start.
In This Episode You'll Learn:
✔ What GLP-1 medications are
✔ How they help manage diabetes and support weight loss
✔ Why they've become so popular
✔ Why Medicare historically did not cover them for weight loss
✔ Why this conversation is becoming increasingly important
✔ What topics we'll explore in future Medicare Maze episodes
🎥 Watch Medicare Maze Episode 1 Here:
https://youtu.be/4Terftp_1Zc
At Thomas Family Insurance, we believe Medicare education should be clear, honest, and easy to understand. Medicare can feel like a maze, but you don't have to navigate it alone.
If there's a Medicare topic you'd like us to cover in a future Medicare Maze episode, please reach out to Trish and let us know. Your question may be featured in an upcoming episode.
Thomas Family Insurance
130 North 5th Street
Quincy, IL 62301
217-771-1723
www.thomfam.com
Helping You Navigate Medicare